Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
Bankers hopeful more supply will follow, but no pipeline forthcoming -
The strong market conditions are tempting cash rich issuers
-
Three borrowers head to euros to fund M&A activity
-
US corporate bond market jumping with deals despite inflation shock on Tuesday
-
Share sale achieved a tight discount of 2.3%
-
IPO volumes on the London Stock Exchange fell to levels not seen since the global financial crisis levels in 2023
